Abeona Therapeutics | DEF 14A: Definitive information statements
Mar 19 07:21 ET
Abeona Therapeutics | 8-K: Current report
Mar 18 08:39 ET
Abeona Therapeutics | 10-K: Annual report
Mar 18 07:39 ET
Abeona Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Vazzano Joseph Walter
Mar 15 17:07 ET
Abeona Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer O'Malley Brendan M.
Mar 12 17:04 ET
Abeona Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Point72 Asset Management, L.P.(6.4%),Point72 Capital Advisors, Inc.(6.4%), etc.
Feb 14 17:44 ET
Abeona Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Nantahala Capital Management, LLC(9.9%),Wilmot B. Harkey(9.9%), etc.
Feb 14 16:59 ET
Abeona Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-EcoR1 Capital, LLC(4.2%),Oleg Nodelman(4.2%), etc.
Feb 14 16:18 ET
Abeona Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(4.99%),Steven Boyd(4.99%)
Feb 14 14:45 ET
Abeona Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deerfield Mgmt, L.P.(3.39%),Deerfield Management Company, L.P.(3.39%), etc.
Feb 12 17:25 ET
Abeona Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Seshadri Vishwas
Feb 7 08:31 ET
Abeona Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Alvino Mark
Jan 22 00:00 ET
Abeona Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Millennium Management LLC(5.7%),Millennium Group Management LLC(5.7%), etc.
Jan 10 00:00 ET
Abeona Therapeutics | 8-K: Current report
Jan 8 00:00 ET
Abeona Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Millennium Management LLC(5.5%),Millennium Group Management LLC(5.5%), etc.
Dec 4, 2023 16:09 ET
Abeona Therapeutics | 8-K: Current report
Nov 27, 2023 07:30 ET
Abeona Therapeutics: Q3 2023 Earnings Report
Nov 13, 2023 08:01 ET
Abeona Therapeutics | 8-K: Abeona Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Developments
Nov 13, 2023 07:35 ET
Abeona Therapeutics | 8-K: Current report
Oct 18, 2023 07:30 ET
Abeona Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Seshadri Vishwas
Oct 17, 2023 16:30 ET
No Data
No Data